StockData
PetMed Express Inc logo

PetMed Express Inc (PETS) stock

PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3058% below fair value
$0.99−0.08 (-7.11%)

Close on Nov 12, 2026Market cap $21.45MP/E –Yield 0.00%

PetMed Express ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

PetMed Express's ebitda for the twelve months ending Sep 30, 2026 was -$19.66M. For fiscal 2026 it was -$49.29M, down 994.6% from the year before. The highest annual figure on record is $27.03M in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$49.29M-994.6%
FY2025Mar 31, 2025$5.51M–
FY2024Mar 31, 2024-$1.11M-111.5%
FY2023Mar 31, 2023$9.60M-64.5%
FY2022Mar 31, 2022$27.03M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ3 2026Sep 30, 2026-$4.24M–
Q1 FY2027CQ2 2026Jun 30, 2026-$4.08M–
Q4 FY2026CQ1 2026Mar 31, 2026-$3.27M–
Q3 FY2026CQ4 2025Dec 31, 2025-$8.07M-810.4%
Q2 FY2026CQ3 2025Sep 30, 2025-$6.10M-375.9%
Q1 FY2026CQ2 2025Jun 30, 2025-$31.85M-621.5%
Q4 FY2025CQ1 2025Mar 31, 2025-$3.95M–
Q3 FY2025CQ4 2024Dec 31, 2024$1.14M–
Q2 FY2025CQ3 2024Sep 30, 2024$2.21M-14.5%
Q1 FY2025CQ2 2024Jun 30, 2024$6.11M–
Q4 FY2024CQ1 2024Mar 31, 2024-$1.94M-348.1%
Q3 FY2024CQ4 2023Dec 31, 2023-$1.30M-858.1%
Q2 FY2024CQ3 2023Sep 30, 2023$2.59M-43.5%
Q1 FY2024CQ2 2023Jun 30, 2023-$450.00K-111.1%
Q4 FY2023CQ1 2023Mar 31, 2023$782.00K–
Q3 FY2023CQ4 2022Dec 31, 2022$172.00K–
Q2 FY2023CQ3 2022Sep 30, 2022$4.58M–
Q1 FY2023CQ2 2022Jun 30, 2022$4.06M–

More PetMed Express figures

See a number that looks wrong?